Comparative Costs of a Parent-Only and Parent and Child Treatment for Children with Overweight or Obesity

Kerri N Boutelle1,2,3, David Strong2, June Liang1

  • 1Department of Pediatrics, UC San Diego, La Jolla, California, USA.

Insights

Parent-based treatment (PBT) is a cost-effective alternative to family-based treatment (FBT) for childhood obesity. This study found PBT to be noninferior to FBT in weight loss outcomes while demonstrating lower costs.

Area of Science:

  • Pediatric Endocrinology
  • Health Economics
  • Behavioral Health

Background:

  • Family-based treatment (FBT) is a leading intervention for childhood obesity.
  • Emerging evidence indicates parent-based treatment (PBT) may be equally effective.
  • Comparative cost-effectiveness of these models requires further investigation.

Purpose of the Study:

  • To compare the economic costs of FBT and PBT for pediatric obesity.
  • To determine if PBT offers a more cost-effective approach than FBT.

Main Methods:

  • A randomized controlled trial involving 150 children with overweight/obesity and their parents.
  • Six-month FBT and PBT intervention programs.
  • Cost analysis from healthcare and limited societal perspectives.

Main Results:

  • PBT demonstrated lower costs per parent-child dyad compared to FBT.
  • Healthcare sector costs: PBT $2,886 vs. FBT $3,899.
  • Limited societal costs: PBT $3,231 vs. FBT $4,279.

Conclusions:

  • Parent-based treatment (PBT) is a cost-effective intervention for pediatric obesity.
  • PBT is noninferior to FBT in achieving weight loss for children and parents.
  • PBT presents a financially viable alternative for childhood obesity management.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
925
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
85
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
462
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
109
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
78
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.6K